Proactive therapeutic drug monitoring of infliximab leads to durability of treatment in children with Inflammatory Bowel Disease

被引:0
|
作者
Chuah, C. W. [1 ]
Eldredge, J. [1 ]
Magoffin, A. [1 ]
O'Loughlin, E., V [1 ]
Park, C. J. [2 ]
Puppi, J. [1 ]
Siew, S. [1 ,3 ]
Stormon, M. [1 ]
Thacker, K. [1 ]
Dutt, S. [1 ,3 ]
机构
[1] Childrens Hosp Westmead, Dept Gastroenterol, Westmead, Australia
[2] Australian Natl Univ, Sydney Adventist Hosp, Clin Sch, Sch Med & Psychol, Canberra, Australia
[3] Univ Sydney, Childrens Hosp Westmead Clin Sch, Sydney Sch Med, Sydney, Australia
来源
关键词
D O I
10.1093/ecco-jcc/jjae190.1321
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1147
引用
收藏
页码:i2099 / i2099
页数:1
相关论文
共 50 条
  • [21] Proactive Therapeutic Drug Monitoring May Reduce the Need for Combination Therapy in Inflammatory Bowel Disease Patients Treated with Infliximab
    Doherty, J.
    Varley, R.
    Dunne, C.
    Mc Carthy, F.
    Hartery, K.
    Mc Kiernan, S.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I391 - I391
  • [22] Cost-effectiveness of utilising proactive Infliximab therapeutic drug monitoring for inflammatory bowel disease in routine clinical practice
    Steen, J.
    McCormack, M.
    McShane, C.
    Healy, M.
    Crowley, V.
    Kennedy, U.
    Hayes, O.
    Dunne, C.
    Hartery, K.
    McKiernan, S.
    MacCarthy, F.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S307 - S308
  • [23] Proactive Therapeutic Drug Monitoring May Reduce the Need for Combination Therapy in Inflammatory Bowel Disease Patients Treated with Infliximab
    Doherty, J.
    Varley, R.
    Dunne, C.
    Mc Carthy, F.
    Hartery, K.
    Mc Kiernan, S.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I391 - I391
  • [24] Therapeutic drug monitoring of infliximab induction therapy in inflammatory bowel disease.
    Sanchez-Hernandez, Jose German
    Fraile, Sofia
    Rebollo, Noemi
    Laso, Esther
    Pordomingo, Alejandra F.
    Calvo, M. V.
    PHARMACOTHERAPY, 2017, 37 (06): : E57 - E57
  • [25] Infliximab Optimization Based on Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease
    Hofmekler, Tatyana
    Bertha, Madeline
    McCracken, Courtney
    Martineau, Benadette
    McKinnon, Elizabeth
    Schoen, Bess T.
    McElhanon, Barbara O.
    Tenjarla, Gayathri
    Kugathasan, Subra
    Sauer, Cary G.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (04): : 580 - 585
  • [26] LONG-TERM OUTCOMES OF PROACTIVE VERSUS REACTIVE THERAPEUTIC DRUG MONITORING FOR OPTIMIZING INFLIXIMAB THERAPY IN INFLAMMATORY BOWEL DISEASE
    Papamichail, Konstantinos
    Chachu, Karen A.
    Vajravelu, Ravy K.
    Vaughn, Byron P.
    Ni, Josephine
    Cheifetz, Adam S.
    Osterman, Mark T.
    GASTROENTEROLOGY, 2017, 152 (05) : S381 - S382
  • [27] Proactive Therapeutic drug monitoring of Infliximab, but not HLA-DQA1*05, predicts clinical outcome in inflammatory bowel disease
    Alonso, I.
    Carrillo Palau, M.
    Vera, B.
    Vela, M.
    Morant, A.
    Ramos, L.
    Reygosa, C.
    Medina Chico, J. S.
    Barrios, Y.
    Franco, A.
    Gutierrez-Nicolas, F.
    Jimenez, A.
    Hernandez-Guerra, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I597 - I597
  • [28] Durability of Infliximab Is Associated With Disease Extent in Children With Inflammatory Bowel Disease
    Shapiro, Jason M.
    Subedi, Shova
    Machan, Jason T.
    Cerezo, Carolina S.
    Ross, Albert M.
    Shalon, Linda B.
    Silverstein, Jared A.
    Herzlinger, Michael I.
    Kasper, Vania
    LeLeiko, Neal S.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (06): : 867 - 872
  • [29] Reactive Versus Proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease Patients Treated With Infliximab: A Self-Fulfilling Prophecy
    Headlam, John
    Ford, Alexander C.
    Gracie, David J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (10) : 1638 - 1638
  • [30] Is Proactive Therapeutic Drug Monitoring Ready for the Spotlight in Inflammatory Bowel Disease? Follow the Data
    Battat, Robert
    Long, Millie D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 (10): : 2029 - 2031